IGF-1 LR3
Long R3 IGF-I | Recombinant IGF-I Analog | Laboratory Research Reference
FOR LABORATORY RESEARCH USE ONLY.
Not intended for use in humans or animals. No consumer, wellness, physique, or sport-related application is represented.
Product Overview
IGF-1 LR3, also known as Long R3 IGF-I, is a modified analog of human insulin-like growth factor I. It is commonly described as an 83-amino-acid IGF-I analog containing a 13-amino-acid N-terminal extension and an arginine substitution at position 3. These structural changes are discussed in cell-culture literature because they reduce interaction with IGF-binding proteins compared with native IGF-I.
In research-catalogue context, IGF-1 LR3 is best positioned as a cell-culture and receptor-signaling reference material. Repligen describes Long R3 IGF-I as a recombinant analog used in mammalian cell-culture systems, including CHO, HEK293, Vero, MDCK, and fibroblast-related workflows.
Technical Specifications
| Parameter | Temporary Specification |
|---|---|
| Product Name | IGF-1 LR3 |
| Also Known As | Long R3 IGF-I, LR3 IGF-I, Long Arg3 IGF-I |
| Material Category | Recombinant IGF-I analog |
| Amino Acid Length | Commonly described as 83 amino acids |
| Structural Features | 13-amino-acid N-terminal extension; Arg substitution at position 3 |
| Research Context | Mammalian cell-culture research, IGF-I receptor signaling models, IGF-binding protein interaction studies |
| Molecular Weight | Approx. 9.1 kDa in many supplier references — confirm by CoA |
| Formula | Do not publish until supplier CoA confirms |
| CAS Number | Do not publish until supplier CoA confirms |
| Format | 1 mg vial, based on current product label |
| Purity | Confirm from batch-specific CoA |
| Storage | Follow supplier CoA |
| Documentation | CoA and identity verification required before final page publication |
Catalogue Description
IGF-1 LR3 is a Long R3 IGF-I research material used as a reference analog in cell-culture and molecular-signaling studies. It is structurally related to human IGF-I and includes modifications that are commonly discussed in relation to IGF-binding protein interaction and IGF-I receptor research.
Compliance Note
IGF-1-related substances are high-sensitivity compounds in sport and regulatory contexts. WADA’s 2026 list includes insulin-like growth factor-1 under peptide hormones, growth factors, related substances, and mimetics. Therefore, this page should stay strictly research-focused and must not include sport, physique, wellness, or personal-use language.
| Strength |
1 mg |
|---|
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
DISCLAIMER:
- Products sold on our website are meant for scientific research purposes only, designed for in vitro testing and lab experimentation exclusively. These products are not intended to be used as foods, drugs or cosmetics, any sort of bodily introduction of the products into humans or animals is strictly prohibited. They must also not be misbranded, misused, or mislabeled, or used for anything other than research and scientific investigation.
- All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
The product’s label clearly states the amount of product a vial contains; some products are offered in different variations. - The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
- Though we make sure packaging, label, seals and writing does not differ from the product photos you see on our website, there is a chance for a minimal deviation.

